Pharmaceuticals & Medical Devices
Featured news
ECL, BEUC and AIM Urge EU Member States to Prioritise Affordable Medicines in Pharma Package Negotiations
As EU governments engage in critical negotiations on the revision of the EU Pharmaceutical Package, the Association of European Cancer Leagues (ECL), the European Consumer Organisation (BEUC), and the......
AIM WELCOMES THE EU CRITICAL MEDICINES ACT AS A STEP TOWARDS EQUITABLE ACCESS AND SUPPLY CHAIN RESILIENCE
The International Association of Mutual Benefit Societies (AIM) welcomes the recent publication of the EU Critical Medicines Act as a crucial initiative to strengthen equitable access to medicines acr......
STATEMENT ON THE EUROPEAN COMMISSION CALL FOR EVIDENCE ON THE CRITICAL MEDICINES ACT
In response to the Commission’s public consultation on the Critical Medicines Act, the International Association of Mutual Benefit Societies (AIM) has submitted its feedback. AIM welcomes the potent......
Other news
Interview with Jean-Pascal Labille, Secretary General of Solidaris on fair drug prices: “Since 2015, drug spending has spiraled out of control”
Mr. Labille, can you tell us about changes in the affordability of med...
Jens Baas, Chairman of the Board of Techniker Krakenkasse on fair medicines prices : “Medicines are now the second highest spending item of the German public health system”
High medicines prices are now a reality in the EU, leading to inequali...
AMR: an ambitious European Plan to tackle an urging global Challenge
AIM, the International Association of Mutual Benefit Societies, welcom...
“A step in the right direction but a more ambitious final legislation is needed” – Mutuals react to the publication of the general pharmaceutical legislation proposal
The much-awaited proposal of the European Commission, aimed at reformi...
“Our health before profit” – Our Belgian member Solidaris launches a campaign to integrate fair pricing of medicinal products in the legislation
Our Belgian member Solidaris, the socialist mutual, launched its campa...
AIM participates in the kick-off of the ASCERTAIN Horizon Europe project
On 24 and 25 January, AIM participated in the kick-off meeting of the...
AIM is part of the ASCERTAIN project to secure access to affordable medicinal products to European patients
AIM participates in a European project on affordability of medicinal p...
Joint Statement on the Revision of the Pharmaceutical Legislation by associations representing healthcare providers, patients, healthcare professionals and payers
Enhancing patients’ access to high-quality and affordable medicinal...
“Better treatment for better health: lifting the veil on treatment optimisation” – Stakeholders exchange views on patient-centred clinical research at EORTC and AIM’s seminar
Treatment optimisation is defined as clinical research in real-world c...